Nasdaq

AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of Psilocybin and Peptide Therapy for Cancer Treatment

NEW YORK, Feb. 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the execution of a Letter of Intent with Silo Pharma Inc. ("Silo") to grant to ...
Nasdaq

AIkido Pharma Announces Peer-Reviewed Publication of Positive Results from Study of Antiviral Compounds Licensed from University of Maryland, Baltimore

NEW YORK, Sept. 11, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the publication of positive results from a study of antiviral activity of FDA ...
Business Insider

AIkido Pharma Inc. Announces Change in the Record Date and Anticipated Distribution Date for Dividend Distribution

NEW YORK, March 13, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company"), formerly known as Spherix Incorporated, today announced that the record date and distribution ...
Business Insider

AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary

Morgan Stanley Executive Joins Dominari Financial, Inc. on July 22, 2022 NEW YORK, July 21, 2022 /PRNewswire/ -- Anthony Hayes, CEO of AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company"), ...
dailyfreeman.com

AIkido Pharma Issues Update on Antiviral Platform with the University of Maryland

NEW YORK, July 16, 2021 /PRNewswire/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided an update to the progress of its antiviral platform with the University of Maryland ...
streetinsider

AIkido Pharma (AIKI) Provides Business Update

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided a business ...